Effect of ferroportin Q248H polymorphism on iron status in African children

Ishmael Kasvosve1, Zvenyika A R Gomo, Kusum J Nathoo

  • 1Department of Chemical Pathology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe. ikasvosve@medsch.uz.ac.zw

Insights

The ferroportin Q248H mutation may offer protection against iron deficiency in African children, particularly when inflammation is present. Further research is needed to confirm this finding in children with repeated inflammatory conditions.

Area of Science:

  • Human Genetics
  • Nutritional Science
  • Pediatric Health

Background:

  • Iron deficiency is prevalent in African children, with limited understanding of genetic factors influencing susceptibility.
  • The ferroportin Q248H mutation, affecting cellular iron export, has been linked to higher iron stores in African adults.

Purpose of the Study:

  • To determine the prevalence of iron deficiency in African children in a low-malaria transmission area.
  • To investigate if the ferroportin Q248H mutation confers protection against iron deficiency in this population.

Main Methods:

  • Blood counts and serum markers of iron status and inflammation were analyzed in 208 preschool children in Harare, Zimbabwe.
  • Iron deficiency was defined using two criteria: serum ferritin and C-reactive protein (CRP), or ferritin and the transferrin receptor to ferritin ratio.
  • Ferroportin Q248H genotype was assessed in all participants.

Main Results:

  • The Q248H mutation was found in 38 heterozygotes and 2 homozygotes.
  • Iron deficiency prevalence was 24.0% or 26.4% depending on the definition used.
  • While the Q248H mutation showed a trend towards protection (OR 0.39, P=0.068), it was not statistically significant after adjustment.
  • A significant interaction between Q248H and elevated CRP was observed, with heterozygotes showing higher ferritin levels when CRP was elevated.

Conclusions:

  • The protective effect of ferroportin Q248H against iron deficiency might be more apparent in children experiencing recurrent inflammation.
  • Further investigation into iron status and the ferroportin Q248H mutation in African children is warranted.
Abstract

Related Concept Videos